| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.11 | 0.06 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.06 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.06 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.06 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.06 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.34 | 0.06 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.06 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |